Reversing the Clock: A New Era in Cellular Rejuvenation?
David Sinclair's work on reversing aging has been revolutionary, but his latest trial raises questions about whether it can truly rewrite the rules of cellular biology.
The first patient to receive Sinclair's epigenetic age restoring therapy, a cocktail designed to restore youthful behavior in specific eye cells, marks a significant milestone in longevity research.